METHOD FOR DETERMINING PROSTATE CANCER, METHOD FOR SELECTING TREATMENT OF PROSTATE CANCER, AND PROPHYLACTIC OR THERAPEUTIC AGENT THEREFOR

摘要

The present invention addresses the problem of providing an efficacious and novel therapeutic method for androgen-dependent prostate cancer and providing a marker that is useful in predicting an effect of a treatment on castration resistant prostate cancer. A double-stranded nucleic acid molecule such as siRNA capable of suppressing the expression of ABHD2 gene is prepared and the progress of androgen-dependent prostate cancer is suppressed thereby. By using the expression of ABHD2 gene as a determination marker, an effect of a treatment on castration resistant prostate cancer is preliminarily predicted.